Intestinal regulation of urinary sodium excretion and the pathophysiology of diabetic kidney disease: a focus on glucagon‐like peptide 1 and dipeptidyl peptidase 4

作者: Volker Vallon , Neil G. Docherty

DOI: 10.1113/EXPPHYSIOL.2014.078766

关键词:

摘要: The tubular hypothesis of glomerular filtration and nephropathy in diabetes is a pathophysiological concept that assigns critical role to the system, including proximal hyperreabsorption growth, which relevant for early hyperfiltration later chronic kidney disease. Here we focus on how harnessing bioactivity hormones released from gut may ameliorate effects part by attenuating growth. endogenous tone glucagon-like peptide 1 (GLP-1)/GLP-1 receptor (GLP-1R) system its pharmacologic activation are nephroprotective independent changes blood glucose. This associated with suppression increases weight hyperfiltration, reflect at least inhibitory Inhibition dipeptidyl peptidase 4 (DPP-4) also glucose involves GLP-1/GLP-1R dependent mechanisms. GLP-1R agonist exendin-4 induces natriuresis via GLP-1R. In contrast, DPP4 inhibition, albeit circulating GLP-1, drives natriuretic response implying other DPP-4 substrates. extent intrarenal DPP-4/GLP-1 contributes all these remains be established as does direct impact renal inflammation.

参考文章(29)
L FORTEJR, Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics Pharmacology & Therapeutics. ,vol. 104, pp. 137- 162 ,(2004) , 10.1016/J.PHARMTHERA.2004.08.007
A J Kenny, A G Booth, S G George, J Ingram, D Kershaw, E J Wood, A R Young, Dipeptidyl peptidase IV, a kidney brush-border serine peptidase. Biochemical Journal. ,vol. 157, pp. 169- 182 ,(1976) , 10.1042/BJ1570169
S. Nakashima, T. Matsui, M. Takeuchi, S.-I. Yamagishi, Linagliptin blocks renal damage in type 1 diabetic rats by suppressing advanced glycation end products-receptor axis. Hormone and Metabolic Research. ,vol. 46, pp. 717- 721 ,(2014) , 10.1055/S-0034-1371892
Hiroki Fujita, Tsukasa Morii, Hiromi Fujishima, Takehiro Sato, Tatsunori Shimizu, Mihoko Hosoba, Katsushi Tsukiyama, Takuma Narita, Takamune Takahashi, Daniel J. Drucker, Yutaka Seino, Yuichiro Yamada, The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential Kidney International. ,vol. 85, pp. 579- 589 ,(2014) , 10.1038/KI.2013.427
Timo Rieg, Maria Gerasimova, Fiona Murray, Takahiro Masuda, Tong Tang, Michael Rose, Daniel J. Drucker, Volker Vallon, Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice. American Journal of Physiology-renal Physiology. ,vol. 303, ,(2012) , 10.1152/AJPRENAL.00259.2012
Scott C Thomson, Ali Kashkouli, Prabhleen Singh, None, Glucagon-like peptide-1 receptor stimulation increases GFR and suppresses proximal reabsorption in the rat. American Journal of Physiology-renal Physiology. ,vol. 304, ,(2013) , 10.1152/AJPRENAL.00064.2012
Volker Vallon, Maria Gerasimova, Michael A. Rose, Takahiro Masuda, Joseph Satriano, Eric Mayoux, Hermann Koepsell, Scott C. Thomson, Timo Rieg, SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice. American Journal of Physiology-renal Physiology. ,vol. 306, ,(2014) , 10.1152/AJPRENAL.00520.2013
Adriana C. C. Girardi, Felix Knauf, Hans-Ulrich Demuth, Peter S. Aronson, Role of dipeptidyl peptidase IV in regulating activity of Na+/H+ exchanger isoform NHE3 in proximal tubule cells American Journal of Physiology-cell Physiology. ,vol. 287, ,(2004) , 10.1152/AJPCELL.00186.2004
P. Schlatter, C. Beglinger, J. Drewe, H. Gutmann, Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells Regulatory Peptides. ,vol. 141, pp. 120- 128 ,(2007) , 10.1016/J.REGPEP.2006.12.016
Ryo Kodera, Kenichi Shikata, Tetsuharu Takatsuka, Kaori Oda, Satoshi Miyamoto, Nobuo Kajitani, Daisho Hirota, Tetsuichiro Ono, Hitomi Kataoka Usui, Hirofumi Makino, Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes Biochemical and Biophysical Research Communications. ,vol. 443, pp. 828- 833 ,(2014) , 10.1016/J.BBRC.2013.12.049